Alcon Inc. is the largest eye care device company in the world, specialized in developing and manufacturing medical devices for surgical ophthalmology and vision care. Originally founded in Fort Worth, Texas in 1945, the Swiss-American corporation is currently co-headquartered in Geneva, Switzerland and Texas. Following its major spin-off from pharmaceutical giant Novartis in 2019, Alcon operates as a completely independent, publicly traded entity listed on both the New York Stock Exchange and the SIX Swiss Exchange under the ticker symbol ALC.